genetic health screening startup Color Genomics has raised $52 million so far in what could end up totaling just over $81 million in equity financing, according to a recent SEC filing.
Color is similar to other genetics startups like 23andMe in that it provides information to you based on the DNA found in a spit tube test. It’s main focus has been in providing a series of genetic cancer screenings in an at-home kit, though the company recently launched a test for hereditary high cholesterol as an indication for possible heart disease and says it plans to release more genetic health screening kits in the future.
The new raise, first spotted by Axios, doesn’t disclose who’s put money in the new round, but previous investors include General Catalyst, Khosla Ventures, Formation 8, Emerson Collective, AME Cloud Ventures, Eric Schmidt’s Innovation Endeavors and various tech angels.
We’ve reached out to Color for more information.